This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Helene Ollat: Innovator in Parkinson's Disease Treatment
Introduction
Helene Ollat is a notable inventor based in Nesle la Gilberde, France. She has made significant contributions to the field of medicine, particularly in the treatment of neurological disorders. Her innovative work has led to the development of a unique approach to treating Parkinson's disease.
Latest Patents
Helene Ollat holds a patent for the use of sulbutiamine in the treatment of Parkinson's disease. This invention relates to the use of sulbutiamine and pharmaceutical compositions thereof for the treatment of not only Parkinson's disease but also schizophrenia, alcoholism, and dysthymia. This patent highlights her commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Ollat is associated with Adir Et Compagnie, where she continues to work on innovative solutions in the pharmaceutical field. Her dedication to research and development has positioned her as a key figure in her organization and the broader medical community.
Collaborations
Throughout her career, Helene has collaborated with esteemed colleagues such as Alain Le Ridant and Laurent Perret. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Helene Ollat's contributions to the treatment of Parkinson's disease through her innovative patent demonstrate her significant impact on the field of medicine. Her work continues to inspire advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile